Health
A target for potential cancer drugs may, in fact, worsen disease – EurekAlert
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting…
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Shp2 is a phosphotyrosine phosphatase; its…
Continue Reading
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
Noosa News14 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call